"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

Dr. Dan Sperling As a radiologist specializing in prostate cancer diagnosis and treatment, I’m writing to share a fear I often hear from my patients. “Will this treatment affect my sex life?” This ...

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during ...

According to the Prostate Cancer Foundation ... There are two ways in which a prostate can grow. With one type, cells grow around the urethra, squeezing it off. With the other type, cells grow ...

As with all products, the MHRA will keep its safety under close review. Prostate cancer is one of the most common cancers in ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...